Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection
Recruiting
Phase 4
Interventional Study
Infection Due to Carbapenem Resistant Acinetobacter
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 188 (estimated)
- Sponsor
- Chiang Mai University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand. The main questions it aims to answer the following main questions:
1. Which group has better clinical response at end of treatment
2. Which group has better clinical response at 72 hours and micrological cure at 7…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ≥ 20 years old patients who have CRAB infections (pneumonia, urinary tract infection, skin and soft tissue infection, bloodstream infection)
* Able to provide informed consent or having a legal proxy who can provide informed consent in case the subject is unable to provide con…
Contacts